Women who had singleton pregnancy, expected to have vaginal delivery and cervical dilatation ≤ 6 cm were included in the trial.
INTRODUCTION

CONTEXT
Oxytocin is a heat-sensitive uterotonic drug and has to be stored in 2 to 8°C to ensure efficacy. In room temperature oxytocin undergoes heat degradation.
In settings where oxytocin is used, attention should be paid to the oxytocin cold chain (i.e. the requirements of a temperature-controlled supply chain). 3 At the end of study, the primary outcome was:
14.5% of those women who received carbetocin and 14.4% who received oxytocin had blood loss of at least 500 mL (or require use of additional uterotonic drug). The secondary outcome of the study was: 1.51% of women in carbetocin and 1.45% of those in oxytocin had at least 1000 mL of blood loss (Table 1 ).
The result of study was: heat stable carbetocin is noninferior to oxytocin to prevent postpartum haemorrhage.
The major side effect of both heat-stable carbetocin and oxytocin observed in the study were chest pain, flushing, abdominal pain and vomiting. These effects were observed in less than 0.5% of either group of study population ( Table 2) .
DISCUSSION
Postpartum haemorrhage is one of major cause of maternal mortality. 
